51263 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 17
14:30 UTC
|
VEEV
Veeva Systems
|
◎ Target | Ken Wong not yet tracked | Outperform | $225.00→ $300.00+33.3% |
|
Aug 17
14:30 UTC
|
SAIL
SailPoint
|
◎ Target | Richard Poland ★★☆☆☆ #2695 | Overweight | $19.00→ $22.00+15.8% |
|
Aug 17
14:30 UTC
|
S
SentinelOne
|
◎ Target | Richard Poland ★★☆☆☆ #2695 | Equal Weight | $16.00→ $22.00+37.5% |
|
Aug 17
14:30 UTC
|
RRC
Range Resources
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Equal Weight | $43.00→ $40.00-7.0% |
|
Aug 17
14:30 UTC
|
PECO
Phillips Edison & Company, Inc.
|
◎ Target | Richard Hightower ★★★☆☆ #1852 | Equal Weight | $45.00→ $46.00+2.2% |
|
Aug 17
14:30 UTC
|
OXY
Occidental Petroleum
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $75.00→ $71.00-5.3% |
|
Aug 17
14:30 UTC
|
OKTA
Okta
|
◎ Target | Saket Kalia ★★★☆☆ #1232 | Overweight | $120.00→ $170.00+41.7% |
|
Aug 17
14:30 UTC
|
NMRK
Newmark Group
|
◎ Target | Brendan Lynch ★★★☆☆ #1874 | Overweight | $19.00→ $20.00+5.3% |
|
Aug 17
14:30 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Richard Hightower ★★★☆☆ #1852 | Equal Weight | $147.00→ $146.00-0.7% |
|
Aug 17
14:30 UTC
|
JLL
Jones Lang LaSalle
|
◎ Target | Brendan Lynch ★★★☆☆ #1874 | Equal Weight | $368.00→ $401.00+9.0% |
|
Aug 17
14:30 UTC
|
ITG
ITG
|
◎ Target | Angel Castillo ★★☆☆☆ #2338 | Overweight | $19.00→ $18.00-5.3% |
|
Aug 17
14:30 UTC
|
GWRE
Guidewire Software
|
◎ Target | Ken Wong not yet tracked | Outperform | $180.00→ $200.00+11.1% |
|
Aug 17
14:30 UTC
|
GEMI
Gemini Space Station
|
◎ Target | James Yaro ★★☆☆☆ #2490 | Sell | $4.00→ $3.50-12.5% |
|
Aug 17
14:30 UTC
|
FWONK
Liberty Media Corporation - Liberty Formula One Series C
|
◎ Target | Curry Baker ★★★☆☆ #1176 | Buy | $125.00→ $134.00+7.2% |
|
Aug 17
14:30 UTC
|
FRT
Federal Realty Investment Trust
|
◎ Target | Richard Hightower ★★★☆☆ #1852 | Equal Weight | $120.00→ $123.00+2.5% |
|
Aug 17
14:30 UTC
|
FANG
Diamondback Energy
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $232.00→ $221.00-4.7% |
|
Aug 17
14:30 UTC
|
EXE
Expand Energy
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Equal Weight | $110.00→ $107.00-2.7% |
|
Aug 17
14:30 UTC
|
ESS
Essex Property Trust
|
◎ Target | Richard Hightower ★★★☆☆ #1852 | Equal Weight | $296.00→ $297.00+0.3% |
|
Aug 17
14:30 UTC
|
EQT
EQT
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $70.00→ $68.00-2.9% |
|
Aug 17
14:30 UTC
|
DVN
Devon Energy
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $62.00→ $58.00-6.5% |
|
Aug 17
14:30 UTC
|
DCH
American Axle & Manufacturing
|
◎ Target | Dan Levy ★★☆☆☆ #2679 | Equal Weight | $8.00→ $9.00+12.5% |
|
Aug 17
14:30 UTC
|
CWK
Cushman & Wakefield
|
◎ Target | Brendan Lynch ★★★☆☆ #1874 | Equal Weight | $15.00→ $16.00+6.7% |
|
Aug 17
14:30 UTC
|
CVX
Chevron
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Equal Weight | $216.00→ $208.00-3.7% |
|
Aug 17
14:30 UTC
|
CPT
Camden Property Trust
|
◎ Target | Richard Hightower ★★★☆☆ #1852 | Equal Weight | $122.00→ $123.00+0.8% |
|
Aug 17
14:30 UTC
|
COP
ConocoPhillips
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $155.00→ $150.00-3.2% |
|
Aug 17
14:30 UTC
|
CELC
Celcuity
|
◎ Target | Brad Canino not yet tracked | Buy | $165.00→ $175.00+6.1% |
|
Aug 17
14:30 UTC
|
CBRE
CBRE Group
|
◎ Target | Brendan Lynch ★★★☆☆ #1874 | Overweight | $180.00→ $183.00+1.7% |
|
Aug 17
14:30 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Eliana Merle ★★★☆☆ #1875 | Overweight | $105.00→ $111.00+5.7% |
|
Aug 17
14:30 UTC
|
ADCT
ADC Therapeutics
|
◎ Target | Michael Schmidt ★★★☆☆ #2246 | Buy | $5.00 |
|
Aug 17
14:30 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
↓ Downgrade | Steve Seedhouse not yet tracked | Overweight→ Neutral | |
|
Aug 17
14:30 UTC
|
ENVX
Enovix
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Aug 17
13:30 UTC
|
SRFM
Surf Air Mobility
|
◎ Target | Austin Moeller ★★★☆☆ #2252 | Hold | $1.50→ $1.00-33.3% |
|
Aug 17
13:30 UTC
|
SIND
Sinda
|
◎ Target | Kevin O'Halloran ★★★☆☆ #1545 | Outperform | $16.00→ $19.00+18.8% |
|
Aug 17
13:30 UTC
|
SECZ
Securitize
|
◎ Target | Mark Palmer ★★★☆☆ #1000 | Buy | $16.00→ $10.00-37.5% |
|
Aug 17
13:30 UTC
|
REGN
Regeneron Pharmaceuticals
|
◎ Target | David Risinger ★★★☆☆ #1065 | Market Perform | $641.00→ $824.00+28.5% |
|
Aug 17
13:30 UTC
|
RCMT
RCM Technologies
|
◎ Target | Bill Sutherland ★★★★☆ #414 | Buy | $36.00→ $45.00+25.0% |
|
Aug 17
13:30 UTC
|
QTRX
Quanterix
|
◎ Target | Kyle Mikson not yet tracked | Hold | $4.00→ $3.00-25.0% |
|
Aug 17
13:30 UTC
|
PTGX
Protagonist Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #2118 | Outperform | $112.00→ $178.00+58.9% |
|
Aug 17
13:30 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Edward Kelly ★★★☆☆ #1680 | Overweight | $115.00→ $100.00-13.0% |
|
Aug 17
13:30 UTC
|
NTSK
Netskope
|
◎ Target | Richard Poland ★★☆☆☆ #2695 | Overweight | $13.00→ $17.00+30.8% |
|
Aug 17
13:30 UTC
|
LONA
Athira Pharma
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $18.00→ $17.00-5.6% |
|
Aug 17
13:30 UTC
|
JD
JD.com
|
◎ Target | Shyam Patil ★★★★★ #197 | Neutral | $35.00→ $30.00-14.3% |
|
Aug 17
13:30 UTC
|
JBS
JBS
|
◎ Target | Pooran Sharma ★★★★☆ #423 | Overweight | $18.00→ $17.00-5.6% |
|
Aug 17
13:30 UTC
|
HRI
Herc
|
◎ Target | Jerry Revich ★★★☆☆ #2207 | Overweight | $176.00→ $218.00+23.9% |
|
Aug 17
13:30 UTC
|
ENOV
Enovis
|
◎ Target | Caitlin Cronin ★★★★★ #125 | Buy | $50.00→ $45.00-10.0% |
|
Aug 17
13:30 UTC
|
ENHA
Enhanced Group
|
◎ Target | Susan Anderson ★★☆☆☆ #2539 | Buy | $6.00→ $5.00-16.7% |
|
Aug 17
13:30 UTC
|
ELMT
Elmet Group
|
◎ Target | Austin Moeller ★★★☆☆ #2252 | Buy | $20.00→ $21.00+5.0% |
|
Aug 17
13:30 UTC
|
DLTR
Dollar Tree
|
◎ Target | Edward Kelly ★★★☆☆ #1680 | Overweight | $145.00→ $155.00+6.9% |
|
Aug 17
13:30 UTC
|
CRDL
Cardiol Therapeutics
|
◎ Target | Edward Nash ★★☆☆☆ #2732 | Buy | $8.00→ $10.00+25.0% |
|
Aug 17
13:30 UTC
|
BVS
Bioventus
|
◎ Target | Caitlin Cronin ★★★★★ #125 | Buy | $15.00→ $19.00+26.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.